Eye imaging study for glaucoma detection
Part of Eyes & vision clinical trials.
This study uses advanced eye scans to compare the eyes of people with glaucoma against those with healthy eyes. It aims to find better ways to detect and monitor glaucoma, which could help preserve vision.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 40 and 85 years old
- You must be able to see 20/40 or better with glasses or contacts
- You must not have had any eye surgery, except for LASIK or cataract surgery
- You must not have diabetic retinopathy or other eye diseases that affect vision
- If you have glaucoma, you must have a visible optic nerve abnormality
- If you are a healthy volunteer, you must have no signs of glaucoma and normal eye pressure
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses a special imaging test (OCT angiography) to look at blood flow around the optic nerve in people with advanced glaucoma. It aims to better understand how glaucoma affects eye circulation, which may help improve future care.
This study uses advanced eye imaging (OCT and OCTA) to understand how the blood vessels and tissue layers in the back of the eye differ between people with glaucoma, people at risk for angle-closure glaucoma, and people with healthy eyes. The findings may help doctors better diagnose and understand these eye conditions.
This study measures how blood flows in the retina and how well the eye regulates that flow. It compares people with early or very early glaucoma to people without glaucoma to see what differences may predict progression.
This study tests new ways to diagnose glaucoma (and sometimes related eye conditions) using eye exams and measurements. It may help improve how doctors detect glaucoma earlier and more accurately.
This study looks at different ways to measure how glaucoma affects your vision over time by comparing visual field results. It may help researchers find better models to track progression so treatment decisions can be made more accurately.
This study tests an artificial intelligence (AI) system that looks at eye images to find early signs of glaucoma, a condition that can damage the optic nerve and lead to vision loss. The goal is to see if the AI can accurately tell apart people with glaucoma from those with healthy eyes, which could help with earlier diagnosis and treatment.
Hear when a new Glaucoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.